Skip to main content

Articles

Page 1 of 23

  1. This study examines colistin resistance in Gram-negative bacteria in Egypt, analyzing prevalence, trends, geographic variations, colistin-carbapenem resistance correlation, and mcr-mediated plasmid resistance.

    Authors: Ahmed Azzam, Haitham Salem, Mahmoud Nazih, Enas Mohamed Lotfy, Fatma E. Hassan and Heba Khaled
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:32
  2. WHO strategy to end Tuberculosis (TB) calls for drug susceptibility testing of Mycobacterium tuberculosis (MTB) for all patients, in high TB burden settings. Thus, this study aimed to investigate the MTB drug res...

    Authors: Breli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, Freisnel Hermeland Mouzinga, Mita Naomie Merveille Dello, Jabar Babatunde Pacome Agbo Achimi Abdul, Christopher Mebiame Biyogho, Rhett Chester Mevyann, Guy Arnault Rogue Mfoumbi Ibinda, Micheska Epola Dibamba Ndanga, Franck Hardain Okemba Okombi, Michel Illoye Ayet, Lemercier Khunell Siele, Roélie Foxie Mizele Kitoti, Jeannhey Christevy Vouvoungui, Alain Maxime Mouanga…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:31
  3. Few studies have investigated the impact of carbapenem-resistant Pseudomonas aeruginosa (CRPA) on long-term outcomes in bronchiectasis. This study aimed to analyze acute exacerbations and mortality in bronchie...

    Authors: Jibo Sun, Qingqing Jia, Wenting Lv, Shijie Zhang, Sitong Liu, Dongguang Wang, Lian Wang, Xiang Tong, Jiehao Chen, Xiaoting Chen, Yongjiang Tang and Hong Fan
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:30
  4. Skull base osteomyelitis (SBO) is a severe disease not only because of its rapid progression and its high mortality: diagnosis and treatment are often protracted and in more than 30% of cases no causative path...

    Authors: Laurenz Althaus, Insa Joost, Katharina Schaumann, Tom Prinzen, Maika Werminghaus, Susann Thyson, Birgit Henrich, Jörg Schipper and Thomas Klenzner
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:29
  5. In times of mold active prophylaxis, invasive aspergillosis (IA) epidemiology is evolving. Presentation in non-neutropenic may differ from neutropenic.

    Authors: Andrea Gutiérrez-Villanueva, Itziar Diego-Yagüe, Isabel Gutiérrez-Martín, Sonia García-Prieto, Edith Gutiérrez-Abreu, Román Fernández-Guitián, Isabel Castilla-Martínez, Naomi Bermejo-Moreno, Nuria Miguel-Ontañon, Jorge Calderón-Parra, Alejandro Callejas-Díaz, Alberto Díaz-de Santiago, Sara de la Fuente-Moral, Elena Múñez-Rubio, Sarela García-Masedo, Isabel Sánchez-Romero…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:28
  6. Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There are few recommendations, and no formal training exists for medical professionals to assist with clinic...

    Authors: Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, Anna E. S. Brooks, Julien Wist, Yaneer Bar-Yam, Stephane Bilodeau, Jennifer Curtin, Rae Duncan, Mark Faghy, Leo Galland, Etheresia Pretorius, Spela Salamon, Danilo Buonsenso, Claire Hastie, Binita Kane…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:27
  7. Ceftazidime/avibactam (CZA)-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae has emerged, typically due to mutations in the blaKPC gene. This study aimed to investigate the clinical and...

    Authors: Szu-Yu Liu, Sheng-Hua Chou, Chien Chuang, Chih-Han Juan, Yu-Chien Ho, Hsiang-Ling Ho, Liang Chen and Yi-Tsung Lin
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:26
  8. The emergence and spread of drug resistance to antimalarial drugs pose a severe threat to effective malaria control and treatment. Although sulfadoxine-pyrimethamine resistance is well-documented, it is still ...

    Authors: Wagaw Abebe, Agenagnew Ashagre, Tadesse Misganaw, Zelalem Dejazmach, Getinet Kumie, Marye Nigatie, Abdu Jemal, Zelalem Asmare, Woldeteklehaymanot Kassahun, Solomon Gedfie, Ermias Getachew, Muluken Gashaw, Sisay Ayana, Yalewayker Gashaw, Assefa Sisay, Selamyhun Tadesse…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:25
  9. Endodontic treatment failures are predominantly attributed to Enterococcus faecalis (E. faecalis) infection, a Gram-positive coccus. E. faecalis forms biofilms, resist multiple antibiotics, and can withstand endo...

    Authors: Toka A. Hakim, Bishoy Maher Zaki, Dalia A. Mohamed, Bob Blasdel, Mohamed A. Gad, Mohamed S. Fayez and Ayman El-Shibiny
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:24
  10. Antimicrobial resistance in Enterobacterales represents a substantial threat in modern clinical practice and the collection of data on the efficacy of new molecules is of paramount importance. Our study aimed to ...

    Authors: Emanuele Palomba, Agnese Comelli, Francesca Saluzzo, Federico Di Marco, Elisa Matarazzo, Noemi Lo Re, Alessandra Bielli, Chiara Silvia Vismara, Antonio Muscatello, Marianna Rossi, Daniela Maria Cirillo, Alessandra Bandera and Andrea Gori
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:23
  11. Nocardia cyriacigeorgica, an opportunistic pathogen, is increasingly implicated in human infections. This pathogen predominantly causes pulmonary infections, leading to acute, subacute, or chronic necrotizing sup...

    Authors: Chen Yang, Yue-xin Zheng, Hong-yi Gu, Hong Chen, Wei Li, Fang Li, Yu-wang Bi, Jing Chen, Fu-kun Wang, Qing-qing Sun, Han-bing Meng, Zuo-hao Wu, Shu Yu, Jiang Gu and Yan Cheng
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:22
  12. Stratified antibiograms are recommended to guide empiric clinical treatment. However, which strata to focus on, the limited number of isolates in identified strata, and the heavy associated workload all pose c...

    Authors: Connie T. Y. Xie, Samantha Martinez, Ceylon V. Simon and Susan M. Poutanen
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:21
  13.  Cefiderocol, a newly introduced siderophore cephalosporin, exhibits activity against various multidrug-resistant (MDR) Gram-negative bacilli (GNB), including producers of Ambler class A, B and D carbapenemase...

    Authors: Massinissa Benyahia, Chloé Magnan, Vincent Jean-Pierre, Romaric Larcher, Adeline Boutet-Dubois, Marie Gaillard, Hélène Marchandin, Stéphanie Genieyz, Madjid Morsli, Jean-Philippe Lavigne and Alix Pantel
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:20
  14. This study aimed to assess the resistance phenotype, virulence phenotype, and genetic characteristics of a blaNDM−1 and blaSHV−12 co-harboring ST65 K2 Klebsiella pneumoniae (KP114), which was isolated from Genera...

    Authors: Yuting Kang, Qiujie Li, Wanting Ma, Chao Xu, Zhuoran Qiu, Wei Jia and Pengtao Wang
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:19
  15. Helicobacter pylori (Hpylori) is known to induce chronic inflammatory conditions, and interactions between the host immune system and pathogen have diverted attention toward investigating its correlation with e...

    Authors: Somayeh Yaslianifard, Fatemeh Sameni, Kimia Kazemi, Yousef Atefpour, Bahareh Hajikhani, Ali Baradaran Bagheri, Shahrooz Yazdani and Masoud Dadashi
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:18
  16. The dissemination of multi-drug-resistant bacteria, particularly Methicillin-resistant Staphylococcus aureus (MRSA), necessitates exploring new alternatives for their control. Bacteriophages are promising antibio...

    Authors: Abanoub A. Zanaty, Tarek Dishisha, Mohamed Abd El-Gawad El-Sayed-Ahmed, Maha M. Abdel-Fattah, Kawkab A. Ahmed and Karim Abdelkader
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:17
  17. Rifamycin agents (rifampicin (RIF), rifapentine (RFP), rifabutin (RFB)) are the cornerstone of tuberculosis (TB) therapy. Rifamycins are metabolized into 25-deacetyl-metabolites, which have been described has ...

    Authors: Charlotte Genestet, Chloé Bourg, Elisabeth Hodille, Olivier Bahuaud, Florence Ader, Sylvain Goutelle and Oana Dumitrescu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:16
  18. An important knowledge gap exists on the epidemiology of blood stream infections (BSIs) in low-middle-income countries (LMICs). In this retrospective analysis, we evaluated the etiology, antimicrobial resistan...

    Authors: Yosan Gebremeskel Andemichael, Eyorusalem Tsehaye Habtetsion, Hagos Hayelom Gulbet, Maedn Hailemariam Eman, Oliver Okoth Achila, Samuel Tekle Mengistu, Azania Werede Andemichael, Abrehet Marikos Buthuamlak, Eyob Yohannes Garoy, Berhe Tesfai and Mohammed Elfatih Hamida
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:15
  19. While the reported incidence of non-tuberculous mycobacterial (NTM) infections is increasing, the true prevalence remains uncertain due to limitations in diagnostics and surveillance. The emergence of rare and...

    Authors: Matúš Dohál, Nils Wetzstein, Michaela Hromádková, Simona Mäsiarová, Erik M. Rasmussen, Peter Kunč, Mária Škereňová, Igor Porvazník, Ivan Solovič, Stefan Niemann, Jarmila Hnilicová, Juraj Mokrý, Věra Dvořáková and Margo Diricks
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:14
  20. Metagenomic next-generation sequencing (mNGS) has greatly improved our understanding of pathogens in infectious diseases such as pulmonary tuberculosis (PTB). However, high human DNA background (> 95%) impedes...

    Authors: Jinfeng Yuan, Liping Ma, Juan Du, Hailin Sun, Shanshan Li, Gang Zhou, Guanhua Rao, Fengshuo Sun, Wangyang Chen, Hui Miao, Dan Tian, Changhao Cheng, Yan Wang, Liang Li, Lifeng Li and Yu Pang
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:13
  21. Carbapenemase-producing Enterobacterales pose a serious clinical threat, particularly in high-burden settings of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae (CREK), where rapid detection tools...

    Authors: Noor Ul Ain, Linzy Elton, Zahra Sadouki, Timothy D. McHugh and Saba Riaz
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:12
  22. Recurrent urinary tract infections (rUTIs) occur in over 20% of patients, with postmenopausal women (over 50 years old) carrying the highest risk for recurrence compared to younger women. Virulence factors suc...

    Authors: Michelle Kalu, Peter Jorth and Annie Wong-Beringer
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:11
  23. Mycobacterium abscessus (MABS) causes difficult-to-treat pulmonary and extra-pulmonary infections. A combination therapy comprising amikacin, cefoxitin, and a macrolide agent is recommended, but its antimicrobial...

    Authors: Etienne Vignaud, Sylvain Goutelle, Charlotte Genestet, Jérôme Guitton, Sabine Cohen, Chloé Bourg, Aurore Durand, Laura Lebouteiller, Albin Bernard, Caroline Richet, Oana Dumitrescu and Elisabeth Hodille
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:10
  24. Highly frequent colorectal cancer (CRC) is predicted to have 3.2 million novel cases by 2040. Tumor microenvironment (TME) bacteriome and metabolites are proposed to be involved in CRC development. In this reg...

    Authors: Hadi Feizi, Hossein Samadi Kafil, Andrey Plotnikov, Vladimir Kataev, Alexander Balkin, Ekaterina Filonchikova, Mohammad Ahangarzadeh Rezaee, Reza Ghotaslou, Mohammad Sadrkabir, Hiva Kadkhoda, Fadhil S. Kamounah and Sergei Nikitin
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:9
  25. Located in the Southwest Indian Ocean area (SIOA), the two French overseas territories (FOTs) of Reunion and Mayotte islands are heavily impacted by antimicrobial resistance. The aim of this study was to inves...

    Authors: Thibaut Vedani, Matthieu Pot, Thomas Garrigos, Loïk Sababadichetty, Marion Daniel, David Wilkinson, Thierry Benoit-Cattin, Olivier Belmonte, Patrick Mavingui, Laurent Dortet and Guillaume Miltgen
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:8
  26. To examine the characteristics and spatiotemporal changes in the phenotypes and genotypes of extended-spectrum β-lactamases (ESBLs) in Escherichia coli strains isolated from bloodstream infections (BSIs) across C...

    Authors: Sayyed Salman, Hao Xu, Yunbo Chen, Jinru Ji, Zhiying Liu and Yonghong Xiao
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:7
  27. We describe pulmonary cryptococcosis in a 28-year-old previously healthy man. Exhaustive immunological investigations revealed a primary NK cell deficiency associated with a secondary impaired anti-Cryptococcus C...

    Authors: Martin Martinot, Shu Shun Li, Catherine Farnarier, Cléa Dubrou, Christelle Piperoglou, Christopher H. Mody and Frederic Vely
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:6
  28. Nemonoxacin is a new quinolone with an antibacterial efficacy against methicillin-resistant Staphylococcus aureus (MRSA). Certain sequence types (STs) have been emerging in Taiwan, including fluoroquinolone-resis...

    Authors: Pao -Yu Chen, Mao-Wang Ho, Po-Liang Lu, Hung-Jen Tang, Cheng Len Sy and Jann-Tay Wang
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:5
  29. Proteus mirabilis (P. mirabilis) is one of the most important causative pathogens associated with complicated urinary tract infections with a 20% incidence. For epidemiological determinations, several phenotypic ...

    Authors: Lamiaa A. Salama, Hazem Hamed Saleh, Shaymaa H. Abdel-Rhman, Rasha Barwa and Ramadan Hassan
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:4
  30. Monotherapy with vancomycin or daptomycin remains guideline-based care for methicillin-resistant Staphylococcus aureus bacteremia (MRSA-B) despite concerns regarding efficacy. Limited data support potential benef...

    Authors: Addison S. Hicks, Mackenzie A. Dolan, Megan D. Shah, Sarah E. Elwood, James A. Platts-Mills, Gregory R. Madden, Zachary S. Elliott and Joshua C. Eby
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:3
  31. Carbapenem-resistant Acinetobacter baumannii (CRAB) is recognized as a common clinical conditional pathogen with blaOXA−23 gene-mediated multidrug-resistance that is a significant threat to public health safety. ...

    Authors: Pengyu Zhang, Jingchen Hao, Yafen Zhang, Junfeng Su, Guozhuang Sun, Jun Xie, Jian Hu and Guocai Li
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:2
  32. The emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant public health concern, as colistin has been the last resort for treating such infections. This study aime...

    Authors: Zijuan Jian, Yanjun Liu, Zhiqian Wang, Peilin Liu, Jiahui Wang, Qun Yan and Wenen Liu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2025 24:1
  33. Non-O1/non-O139 Vibrio cholerae (NOVC) strains are a distinct group of Vibrio cholerae that do not cause epidemic cholera. NOVC infections usually cause mild forms of gastroenteritis, and rarely severe (extra)int...

    Authors: Coen Veenstra, Marion Kolader, Sébastien Matamoros and Kim Sigaloff
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:109
  34. Colonisation and infection with Carbapenem-resistant Enterobacterales (CRE) in healthcare settings poses significant risks, especially for vulnerable patients. Genomic analysis can be used to trace transmissio...

    Authors: Linzy Elton, Alan Williams, Shanom Ali, Jelena Heaphy, Vicky Pang, Liam Commins, Conor O’Brien, Özge Yetiş, Estelle Caine, Imogen Ward, Monika Muzslay, Samuel Yui, Kush Karia, Ellinor Shore, Sylvia Rofael, Damien J. F. Mack…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:108
  35. Antimicrobial resistance (AMR) poses a significant threat to pediatric health; therefore, precise identification of pathogens as well as AMR is imperative. This study aimed at comprehending antibiotic resistan...

    Authors: Nan Zhang, Xiaojing Zhang, Yuxin Guo, Yafeng Zheng, Wei Gai and Zihao Yang
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:107
  36. In June 2022, a 73-year-old man with a history of laryngeal and esophageal carcinoma was admitted to the emergency unit with sudden fever, confusion, and general condition deterioration. Initial assessments sh...

    Authors: Ilyès Benhalima, Lola Jacquemont, Laurine Milière, Alina Tone, Nicolas Ettahar, Gisèle Dewulf and Edith Mazars
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:106
  37. Drug susceptibility testing (DST) for Nocardia spp. is essential to initiate effective antibiotic therapy. Currently, the only recommended technique is the determination of minimum inhibitory concentrations (MICs...

    Authors: Clémence Prudhomme, Brune Joannard, Gérard Lina, Eleonore De Launay, Oana Dumitrescu and Elisabeth Hodille
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:105
  38. During prolonged FDC therapy, the emergence of FDC non-susceptibility in CRAB has been reported. Here, we report a transmission cluster of FDC-non-susceptible CRAB in four patients, all naïve to FDC treatment,...

    Authors: Claudia Alteri, Antonio Teri, Maria Francesca Liporace, Antonio Muscatello, Leonardo Terranova, Margherita Carnevale Schianca, Federica Salari, Beatrice Silvia Orena, Flaminia Gentiloni Silverj, Mara Bernazzani, Simona Biscarini, Giulia Renisi, Lisa Cariani, Caterina Matinato, Ciro Canetta, Alessandra Bandera…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:104
  39. The permeability of the outer membrane barrier modulates the susceptibility of microorganisms to antimicrobial agents. Loss or structural alterations of porins contribute to decreased antibiotic concentration ...

    Authors: Cristina Elías-López, Montserrat Muñoz-Rosa, Julia Guzmán-Puche, Elena Pérez-Nadales, Eduardo Chicano-Galvez and Luis Martínez-Martínez
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:103
  40. This study elucidates the in vivo genetic mechanisms contributing to the emerging resistance to carbapenem in Shewanella algae through a lens of adaptive microbial evolution. Leveraging PacBio amplification-free ...

    Authors: Yao-Ting Huang and Po-Yu Liu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:102
  41. Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to impaired insulin production or utilization, leading to severe health complications. Diabetic foot ulcers (DFUs...

    Authors: Mohsen Nazari, Mohammad Taheri, Fatemeh Nouri, Maryam Bahmanzadeh and Mohammad Yousef Alikhani
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:101
  42. Candida glabrata is the second most common cause of invasive candidiasis worldwide. In this study, we determined the clinical characteristics and drug sensitivity of C. glabrata isolates and investigated the asso...

    Authors: Guanyi Zhang, Yisheng Chen, Jia Chen and Dongting Yao
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:100
  43. Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant threat to immunocompromised populations, including lung transplant recipients. This study investigates mixed CRKP strains carrying either blaK...

    Authors: Zichen Lei, Ziyao Li, Yulin Zhang, Lingbing Zeng, Yongli Wu, Feilong Zhang, Xinrui Yang, Xinmeng Liu, Qi Liu, Yiqun Ma and Binghuai Lu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:99
  44. Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging global threat, whereas its epidemiological characteristics in children are rarely reported. This study aims to analyze clinical and epidemiological...

    Authors: Jiayue Ma, Kaijie Gao, Mingchao Li, Juanjuan Zhou, Xiaorui Song, Yaodong Zhang, Zhidan Yu, Zengyuan Yu, Weyland Cheng, Wancun Zhang, Adong Shen, Junmei Yang, Huiqing Sun and Lifeng Li
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:98
  45. Immunopathology of human tuberculosis (TB) in a subgroup of patients is characterized by aberrantly high concentrations of inflammatory cytokines, for example Interleukin (IL)-6. Concomitant (co-)infections by...

    Authors: Augustine Yeboah, Monikamira Vivekanandan, Ernest Adankwah, Dorcas O. Owusu, Wilfred Aniagyei, Difery Minadzi, Isaac Acheampong, Joseph F. Arthur, Millicent Lamptey, Mohammed K. Abass, Francis Kumbel, Francis Osei-Yeboah, Amidu Gawusu, Linda Batsa Debrah, Alexander Debrah, Ertan Mayatepek…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:97
  46. Multiple studies have demonstrated the utility of sonication to improve culture yield in patients with cardiovascular implantable electronic device (CIED) infections.

    Authors: Guillermo Martín-Gutiérrez, Carlos Martín-Pérez, José Manuel Ortiz-de la Rosa, Encarnación Gutiérrez-Carretero, Arístides de Alarcón and José Antonio Lepe
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:96
  47. It is presently considered that Corynebacterium especially Corynebacterium kroppenstedtii (CK) infection, is one of the important causes of granulomatous lobular mastitis (GLM). However, the pathogen of mastit...

    Authors: Yifei Zeng, Mengjie Wang, Xiang Gao, Dongxiao Zhang, Na Fu, Wenjie Zhao and Qiao Huang
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:95
  48. This study aims to present a case of persistent mycetoma caused by Scedosporium boydii and undertake a systematic literature overview to elucidate the clinical characteristics and antifungal treatment exhibited b...

    Authors: Yanping Xiao, Xiaolin Li, Longhua Hu, Yuhui Xu, Xingwei Cao and Qiaoshi Zhong
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:94
  49. Pediatric patients are vulnerable to the threat of carbapenem-resistant Klebsiella pneumoniae (CRKP) due to their limited immunity and few available antibiotics. Especially when these pathogens exhibit hypervirul...

    Authors: Zhangrui Zeng, Caihong Ye, Jingchen Hao, Miran Tang, Xue Xiao, Chunxia Jian, Jinglan Guo, Yinhuan Ding and Jinbo Liu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2024 23:91